Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 75
Filter
Add more filters










Publication year range
1.
Lassa fever in Nigeria.
Adepoju, Paul.
Lancet Microbe ; : 100960, 2024 Aug 20.
Article in English | MEDLINE | ID: mdl-39178871
2.
Mpox declared a public health emergency.
Adepoju, Paul.
Lancet ; 404(10454): e1-e2, 2024 Aug 24.
Article in English | MEDLINE | ID: mdl-39182498

Subject(s)
Mpox (monkeypox) , Public Health , Humans , Emergencies , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/prevention & control
3.
African mpox surges show lack of vaccine access.
Adepoju, Paul.
Lancet ; 404(10447): 18, 2024 Jul 06.
Article in English | MEDLINE | ID: mdl-38972316

Subject(s)
Health Services Accessibility , Mpox (monkeypox) , Viral Vaccines , Humans , Africa , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/prevention & control , Viral Vaccines/supply & distribution
4.
Nigeria mandates reporting of all cancer diagnoses.
Adepoju, Paul.
Lancet Oncol ; 25(8): 959, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38972326

Subject(s)
Neoplasms , Humans , Neoplasms/diagnosis , Neoplasms/epidemiology , Nigeria/epidemiology , Mandatory Reporting , Disease Notification/legislation & jurisprudence , Disease Notification/standards
5.
Over US$100 million pledged to improve cancer care across Africa.
Adepoju, Paul.
Lancet Oncol ; 25(9): 1119, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39068944
6.
Cancer updates from the 77th World Health Assembly.
Adepoju, Paul.
Lancet Oncol ; 25(7): 838, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38852603

Subject(s)
Global Health , Neoplasms , World Health Organization , Humans , Neoplasms/therapy
7.
Meet the PrEP ambassadors who use social media to combat HIV.
Adepoju, Paul.
Nat Med ; 30(6): 1510-1512, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38877114

Subject(s)
HIV Infections , Social Media , Humans , HIV Infections/prevention & control , Anti-HIV Agents/therapeutic use
8.
New Zealand expands cancer treatment with funding boost.
Adepoju, Paul.
Lancet Oncol ; 25(8): 958, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38945147

Subject(s)
Neoplasms , Humans , New Zealand , Neoplasms/economics , Neoplasms/drug therapy , Neoplasms/therapy , Financing, Government/economics
9.
South Africa takes on drug-resistant tuberculosis.
Adepoju, Paul.
Lancet Infect Dis ; 24(7): e423, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38908386

Subject(s)
Antitubercular Agents , Tuberculosis, Multidrug-Resistant , Humans , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/epidemiology , South Africa/epidemiology , Antitubercular Agents/therapeutic use , Mycobacterium tuberculosis/drug effects
10.
Kenya sounds alarm over counterfeit cancer drugs.
Adepoju, Paul.
Lancet Oncol ; 25(7): 834, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38797186

Subject(s)
Antineoplastic Agents , Counterfeit Drugs , Humans , Kenya , Counterfeit Drugs/adverse effects , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Neoplasms/drug therapy
11.
Call for actions to address hepatocellular carcinoma in sub-Saharan Africa.
Adepoju, Paul.
Lancet Oncol ; 25(7): 833, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38797185

Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Humans , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/therapy , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/epidemiology , Liver Neoplasms/therapy , Liver Neoplasms/pathology , Africa South of the Sahara/epidemiology
12.
Protests in South Africa over unused cancer-treatment fund.
Adepoju, Paul.
Lancet Oncol ; 25(6): 700-701, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38740031
13.
Nigeria revitalises national cancer response with new initiatives.
Adepoju, Paul.
Lancet Oncol ; 25(5): 544, 2024 May.
Article in English | MEDLINE | ID: mdl-38621401
14.
Initiatives to target cancer care and research in Africa.
Adepoju, Paul.
Lancet Oncol ; 25(6): 696-697, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38679031

Subject(s)
Biomedical Research , Neoplasms , Humans , Neoplasms/therapy , Neoplasms/epidemiology , Africa/epidemiology
15.
Moderna stalls on African vaccine manufacturing plans.
Adepoju, Paul.
Lancet ; 403(10437): 1617, 2024 Apr 27.
Article in English | MEDLINE | ID: mdl-38679023

Subject(s)
Drug Industry , Humans , Africa , COVID-19 Vaccines/supply & distribution , Vaccines
16.
Routine malaria vaccinations begin.
Adepoju, Paul.
Lancet ; 403(10425): 423, 2024 Feb 03.
Article in English | MEDLINE | ID: mdl-38310887

Subject(s)
Antimalarials , Malaria , Humans , Malaria/prevention & control , Malaria/drug therapy , Antimalarials/therapeutic use , Vaccination
17.
CPHIA 2023.
Adepoju, Paul.
Lancet Microbe ; 5(3): e215, 2024 03.
Article in English | MEDLINE | ID: mdl-38309284
18.
The next chapter for Africa's genomic initiatives.
Adepoju, Paul.
Lancet Infect Dis ; 24(3): e160, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38401564

Subject(s)
Genomics , Humans , Africa
19.
Healthcare workforce shortages exacerbated by poaching from the global South.
Adepoju, Paul.
Nat Med ; 30(2): 311-314, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38200258

Subject(s)
Delivery of Health Care , Health Personnel , Humans , Workforce
20.
Nigeria targets almost 8 million girls with HPV vaccine.
Adepoju, Paul.
Lancet ; 402(10413): 1612, 2023 11 04.
Article in English | MEDLINE | ID: mdl-37926106

Subject(s)
Papillomavirus Infections , Papillomavirus Vaccines , Uterine Cervical Neoplasms , Female , Humans , Nigeria/epidemiology , Uterine Cervical Neoplasms/prevention & control , Papillomavirus Infections/prevention & control , Vaccination , Health Knowledge, Attitudes, Practice
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL